Logo.png
Interpace to Present at the American College of Gastroenterology Conference
24 oct. 2019 06h55 HE | Interpace Diagnostics Group, Inc.
Interpace hosts 2nd Annual Fellow Programs PARSIPPANY, NJ, Oct. 24, 2019 (GLOBE NEWSWIRE) -- Interpace (IDXG) announced today that it will be presenting new data on the performance of its...
Logo.png
Interpace Announces Closing of $13 Million Second Tranche Acquisition Financing from Ampersand Capital Partners
17 oct. 2019 06h55 HE | Interpace Diagnostics Group, Inc.
PARSIPPANY, NJ, Oct. 17, 2019 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (IDXG) announced today that it has closed on a $13 million Convertible Preferred Stock investment by Ampersand...
Logo.png
Interpace Named to ‘Most Admired Companies’ List
15 oct. 2019 06h55 HE | Interpace Diagnostics Group, Inc.
PARSIPPANY, NJ, Oct. 15, 2019 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ: IDXG) announced today that it has been named one of the 50 Most Admired Companies of the Year by The...
Logo.png
Interpace Announces New Contracts with Multiple Blue Cross Blue Shield Plans
30 sept. 2019 06h55 HE | Interpace Diagnostics Group, Inc.
In-Network Access for Thyroid Assays for More than 5 Million Members PARSIPPANY, NJ, Sept. 30, 2019 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ: IDXG) announced today that it...
Logo.png
Interpace to Present at The Ladenburg Thalmann 2019 Healthcare Conference
18 sept. 2019 06h55 HE | Interpace Diagnostics Group, Inc.
PARSIPPANY, NJ, Sept. 18, 2019 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (“Interpace” or the “Company”) (NASDAQ: IDXG) today announced that the Company will present at the upcoming...
Logo.png
Interpace Diagnostics Reports Second Quarter 2019 Financial Results and Provides Business Update
13 août 2019 08h15 HE | Interpace Diagnostics Group, Inc.
Second Quarter Revenue Grew 14% Over the Prior Year and 19% Year to Date Over the Prior Year Acquired Growing BioPharma Services Business Net Revenue Guidance Increased Conference Call and...
Logo.png
Interpace Diagnostics to Host Conference Call and Webcast to Discuss Second Quarter 2019 Financial Results on Tuesday, August 13, 2019
06 août 2019 16h05 HE | Interpace Diagnostics Group, Inc.
PARSIPPANY, NJ, Aug. 06, 2019 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ: IDXG) announced today that it will report its second quarter 2019 financial results on Tuesday, August...
Logo.png
Interpace Diagnostics Announces Coverage of Molecular Thyroid Testing by Independence Blue Cross
20 juin 2019 06h55 HE | Interpace Diagnostics Group, Inc.
PARSIPPANY NJ, June 20, 2019 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ: IDXG) announced today that its ThyGeNEXT™ and ThyraMIR® tests for thyroid cancer are now covered by...
Logo.png
Interpace Diagnostics Announces Presentation at the World Congress on Thyroid Cancer
13 juin 2019 06h55 HE | Interpace Diagnostics Group, Inc.
Rome, ITALY, June 13, 2019 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ: IDXG), a fully integrated bioinformatics and commercial molecular diagnostic company, today announced that...
IDXG Logo.jpg
Interpace Diagnostics BarreGEN® Data to be Presented at Digestive Disease Week
09 mai 2019 06h55 HE | Interpace Diagnostics Group, Inc.
Company to Host Fellowship and Key Opinion Leader Programs PARSIPPANY, NJ, May 09, 2019 (GLOBE NEWSWIRE) --  Interpace Diagnostics Group, Inc. (NASDAQ: IDXG) announced today that data from an...